# COVID-19 Disease Duration and GIT Manifestations. A New Disease Severity Classification. An Egyptian Experience

> **NCT04554979** · — · COMPLETED · sponsor: **Cairo University** · enrollment: 199 (actual)

## Conditions studied

- Covid19
- Diarrhea

## Interventions

- **DRUG:** Hydroxychloroquine Pill

## Key facts

- **NCT ID:** NCT04554979
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-01
- **Primary completion:** 2020-07-15
- **Final completion:** 2020-07-15
- **Target enrollment:** 199 (ACTUAL)
- **Last updated:** 2020-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04554979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04554979, "COVID-19 Disease Duration and GIT Manifestations. A New Disease Severity Classification. An Egyptian Experience". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04554979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*